Product
Diluted I.V.-Hepabig
1 clinical trial
1 indication
Indication
Hepatitis BClinical trial
A Phase 3b Study to Investigate the Safety and Efficacy of Undiluted Intravenous Infusion of I.V.-Hepabig Inj. in Post-liver Transplant PatientsStatus: Recruiting, Estimated PCD: 2024-12-01